Association between arterial stiffness and variations in oestrogen-related genes

Journal of Human Hypertension

Volumn 23, Issue 10, 2009, Pages 636-644

  Peter, I ^a   Kelley Hedgepeth, A ^b   Huggins, G S ^b   Housman, D E ^c   Mendelsohn, M E ^b   Vita, J A ^d,e   Vasan, R S ^d,e   Levy, D ^d,f   Benjamin, E J ^d,e,g   Mitchell, G F ^h  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g BOSTON UNIVERSITY   (United States)

^h CARDIOVASCULAR ENGINEERING INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ADULT; ALLELE; ARTERIAL STIFFNESS; ARTERY TONE; ARTICLE; AUGMENTATION INDEX; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CAROTID ARTERY PULSE; CONFOUNDING VARIABLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEART RATE; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NON INVASIVE MEASUREMENT; PULSE WAVE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TONOMETRY; VASODILATATION;

AGED; AROMATASE; ARTERIES; BLOOD PRESSURE; BRACHIAL ARTERY; CAROTID ARTERIES; ELASTICITY; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; FEMORAL ARTERY; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MANOMETRY; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULSATILE FLOW; ULTRASONOGRAPHY, DOPPLER;

EID: 70349445393     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.1     Document Type: Article

References (46)

1. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA et al. Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam Study. Circulation 2006; 113 657-663.
2. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005; 111: 3384-3390.
3. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113: 664-670.
4. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105-1110.
5. Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: The Framingham Heart Study. Hypertension 2004; 43: 1239-1245.
6. Gatzka CD, Kingwell BA, Cameron JD, Berry KL, Liang YL, Dewar EM et al. Gender differences in the timing of arterial wave reflection beyond differences in body height. J Hypertens 2001; 19: 2197-2203.
7. Kalantaridou SN, Naka KK, Papanikolaou E, Kazakos N, Kravariti M, Calis KA et al. Impaired endothelial function in young women with premature ovarian failure: Normalization with hormone therapy. J Clin Endocrinol Metab 2004; 89: 3907-3913.
8. Kalantaridou SN, Naka KK, Bechlioulis A, Makrigiannakis A, Michalis L, Chrousos GP. Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement. Trends Endocrinol Metab 2006; 17: 101-109.
9. Sumino H, Ichikawa S, Kasama S, Takahashi T, Kumakura H, Takayama Y et al. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women. Atherosclerosis 2006; 189: 436-442.
10. Gerhard M, Walsh BW, Tawakol A, Haley EA, Creager SJ, Seely EW et al Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation 1998; 98: 1158-1163.
11. Mendelsohn ME. Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 2002; 90: 3F-6F.
12. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
13. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-1777.
14. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2 1057-1058.
15. Venkov CD, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996; 94: 727-733.
16. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994; 89: 1943-1950.
17. Shearman AM, Cupples LA, Demissie S, Peter I, Schmid CH, Karas RH et al. Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA 2003; 290: 2263-2270.
18. Lu H, Higashikata T, Inazu A, Nohara A, Yu W, Shimizu M et al. Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2002; 22: 817-823.
19. Pollak A, Rokach A, Blumenfeld A, Rosen LJ, Resnik L, Dresner PR. Association of oestrogen receptor alpha gene polymorphism with the angiographic extent of coronary artery disease. Eur Heart J 2004; 25: 240-245.
20. Rokach A, Pollak A, Rosen L, Friedlander Y, Blumenfeld A, Reznik L et al. Estrogen receptor alpha gene polymorphisms are associated with the angiographic extent of coronary artery disease. J Clin Endocrinol Metab 2005; 90: 6556-6560.
21. Peter I, Shearman AM, Zucker DR, Schmid CH, Demissie S, Cupples LA et al. Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens 2005; 23: 2193-2200.
22. Shearman AM, Demissie S, Cupples LA, Peter I, Schmid CH, Ordovas JM et al. Tobacco smoking, estrogen receptor alpha gene variation and small low density lipoprotein level. Hum Mol Genet 2005; 14: 2405-2413.
23. Demissie S, Cupples LA, Shearman AM, Gruenthal KM, Peter I, Schmid CH et al. Estrogen receptor-alpha variants are associated with lipoprotein size distribution and particle levels in women: The Framingham Heart Study. Atherosclerosis 2006; 185: 210-218.
24. Fox CS, Yang Q, Cupples LA, Guo CY, Atwood LD, Murabito JM et al. Sex-specific association between estrogen receptor-alpha gene variation and measures of adiposity: The Framingham Heart Study. J Clin Endocrinol Metab 2005; 90: 6257-6262.
25. Leibowitz D, Dresner-Pollak R, Dvir S, Rokach A, Reznik L, Pollak A. Association of an estrogen receptor-alpha gene polymorphism with left ventricular mass. Blood Press 2006; 15: 45-50.
26. Peter I, Huggins GS, Shearman AM, Pollak A, Schmid CH, Cupples LA et al. Age-related changes in echo-cardiographic measurements: association with variation in the estrogen receptor-alpha gene. Hypertension 2007; 49: 1000-1006.
27. Peter I, Shearman AM, Vasan RS, Zucker DR, Schmid CH, Demissie S et al. Association of estrogen receptor beta gene polymorphisms with left ventricular mass and wall thickness in women. Am J Hypertens 2005; 18: 1388-1395.
28. Baghaei F, Rosmond R, Westberg L, Hellstrand M, Eriksson E, Holm G et al. The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Obes Res 2003; 11: 578-585.
29. Snieder H, Hayward CS, Perks U, Kelly RP, Kelly PJ, Spector TD. Heritability of central systolic pressure augmentation: A twin study. Hypertension 2000; 35: 574-579.
30. Mitchell GF, DeStefano AL, Larson MG, Benjamin EJ, Chen MH, Vasan RS et al. Heritability and a genomewide linkage scan for arterial stiffness, wave reflection, and mean arterial pressure: The Framingham Heart Study. Circulation 2005; 112: 194-199.
31. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979; 110: 281-290.
32. Murgo JP, Westerhof N, Giolma JP, Altobelli SA. Aortic input impedance in normal man: Relationship to pressure wave forms. Circulation 1980; 62: 105-116.
33. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney Jr JF et al. Clinical correlates and heritability of flow-mediated dilation in the community: The Framingham Heart Study. Circulation 2004; 109: 613-619.
34. Mitchell GF, Parise H, Vita JA, Larson MG, Warner E, Keaney Jr JF et al. Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension 2004; 44: 134-139.
35. Shearman AM, Karasik D, Gruenthal KM, Demissie S, Cupples LA, Housman DE et al. Estrogen receptor beta polymorphisms are associated with bone mass in women and men: The Framingham Study. J Bone Miner Res 2004; 19: 773-781.
36. Peter I, Kelley-Hedgepeth A, Fox CS, Cupples LA, Huggins GS, Housman DE et al. Variation in estrogen-related genes associated with cardiovascular phenotypes and circulating estradiol, testosterone, and dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 2008; 93: 2779-2785.
37. Lewontin RC. The interaction of selection and linkage. II. Optimum models. Genetics 1964; 50: 757-782.
38. Elston RC, Olson JM, Palmer L. Biostatistical Genetics and Genetic Epidemiology. John Wiley & Sons, Ltd: Chichester, West Sussex, England, 2003.
39. Sano M, Inoue S, Hosoi T, Ouchi Y, Emi M, Shiraki M et al. Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 1995; 217: 378-383.
40. Kos M, Reid G, Denger S, Gannon F. Minireview: Genomic organization of the human ERalpha gene promoter region. Mol Endocrinol 2001; 15 2057-2063.
41. Kunnas TA, Laippala P, Penttila A, Lehtimaki T, Karhunen PJ. Association of polymorphism of human alpha oestrogen receptor gene with coronary artery disease in men: A necropsy study. BMJ 2000; 321: 273-274.
42. Moriarty K, Kim KH, Bender JR. Minireview: Estrogen receptor-mediated rapid signaling. Endocrinology 2006; 147: 5557-5563.
43. Herrington DM, Howard TD, Brosnihan KB, McDonnell DP, Li X, Hawkins GA et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 2002; 105: 1879-1882.
44. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002; 295: 505-508.
45. Hayashi K, Maeda S, Iemitsu M, Otsuki T, Sugawara J, Tanabe T et al Sex differences in the relationship between estrogen receptor alpha gene polymorphisms and arterial stiffness in older humans. Am J Hypertens 2007; 20: 650-656.
46. Garcia-Fernandez R, Perez-Velasco JG, Concepcion-Millan A, Sosa S, Navaroli F, Garcia-Barreto D. Estrogen does not prevent endothelial dysfunction caused by cigarette smoking. Clin Cardiol 2004; 2 71-73.